B. Metzler Seel. Sohn & Co. Ag Atri Cure, Inc. Call Options Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.07 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATRC
# of Institutions
239Shares Held
46.7MCall Options Held
95.7KPut Options Held
119K-
Vanguard Group Inc Valley Forge, PA4.75MShares$113 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.23MShares$100 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.65MShares$86.5 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.68MShares$63.5 Million0.48% of portfolio
-
Wellington Management Group LLP Boston, MA1.64MShares$38.8 Million0.01% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.1B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...